Adherex Technologies Inc. (TSX: AHX)(AMEX: ADH), a biopharmaceutical
company devoted to solving problems for patients with cancer, announced
today the activation of a Phase III trial with...
Adherex Technologies Inc. (AMEX:ADH Stock Message Boards) (TSX:AHX), a biopharmaceutical
company with many oncology products under development, reported financial results for the third quarter...
Adherex Technologies Inc. (TSX: AHX)(AMEX: ADH), a biopharmaceutical
company with a broad portfolio of oncology products under development,
today announced that Phase II clinical data on...